Suvira Ramlall1, Richard J Lessells2,3, Thirusha Naidu4, Sbusisiwe Sandra Mthembu5, Nesri Padayatchi3, Jonathan K Burns1,6, Andrew Tomita2,7. 1. Department of Psychiatry, University of KwaZulu-Natal, Durban, South Africa. 2. KwaZulu-Natal Research Innovation and Sequencing Platform, University of KwaZulu-Natal, Durban, South Africa. 3. Centre for the AIDS Programme of Research in South Africa, Durban, South Africa. 4. Department of Behavioural Medicine, University of KwaZulu-Natal, Durban, South Africa. 5. South African Medical Research Council, Durban, South Africa. 6. Institute of Health Research, University of Exeter, Exeter, UK. 7. Centre for Rural Health, University of KwaZulu-Natal, Durban, South Africa.
Abstract
OBJECTIVES: Optimising medication adherence is one of the essential factors in reversing the tide of a TB-HIV syndemic in sub-Saharan Africa, especially South Africa. Impairment in key neurocognitive domains may impair patients' ability to maintain adherence to treatment, but the level of cognition and its relationship to HIV status has not been examined in individuals with drug-resistant TB. We therefore investigated performance on several key neurocognitive domains in relationship to HIV status in a multidrug-resistant tuberculosis patients (MDR-TB) sample. METHODS: We enrolled microbiologically confirmed MDR-TB inpatients at a TB-specialist referral hospital in KwaZulu-Natal province, South Africa. We collected cross-sectional data on sociodemographic, clinical and neurocognitive function (e.g. attention, memory, executive functioning, language fluency, visual-spatial, eye-hand coordination). For the primary analysis, we excluded participants with major depressive episode/substance use disorder (MDE/SUD). We fitted adjusted Poisson regression models to explore the association between HIV and neurocognitive function. RESULTS: We enrolled 200 people with MDR-TB; 33 had MDE/SUD, and data of 167 were analysed (151 HIV+, 16 HIV-). The mean age of participants was 34.2 years; the majority were female (83%), and 53% had not completed secondary school. There was evidence of impaired neurocognitive functioning across all domains in both HIV+/- study participants. Based on the regression analyses, individuals with co-infection (MDR-TB/HIV+), as well as those who had longer duration of hospital stays experienced significantly lower cognitive performance in several domains. Poor cognitive performance was significantly related to older age and lower educational attainment. The presence of major depression or substance use disorders did not influence the significance of the findings. CONCLUSIONS: Adults with MDR-TB have significant neurocognitive impairment, especially if HIV positive. An integrated approach is necessary in the management of MDR-TB as cognitive health influences the ability to adhere to chronic treatment, clinical outcomes and functionality.
OBJECTIVES: Optimising medication adherence is one of the essential factors in reversing the tide of a TB-HIV syndemic in sub-Saharan Africa, especially South Africa. Impairment in key neurocognitive domains may impair patients' ability to maintain adherence to treatment, but the level of cognition and its relationship to HIV status has not been examined in individuals with drug-resistant TB. We therefore investigated performance on several key neurocognitive domains in relationship to HIV status in a multidrug-resistant tuberculosispatients (MDR-TB) sample. METHODS: We enrolled microbiologically confirmed MDR-TB inpatients at a TB-specialist referral hospital in KwaZulu-Natal province, South Africa. We collected cross-sectional data on sociodemographic, clinical and neurocognitive function (e.g. attention, memory, executive functioning, language fluency, visual-spatial, eye-hand coordination). For the primary analysis, we excluded participants with major depressive episode/substance use disorder (MDE/SUD). We fitted adjusted Poisson regression models to explore the association between HIV and neurocognitive function. RESULTS: We enrolled 200 people with MDR-TB; 33 had MDE/SUD, and data of 167 were analysed (151 HIV+, 16 HIV-). The mean age of participants was 34.2 years; the majority were female (83%), and 53% had not completed secondary school. There was evidence of impaired neurocognitive functioning across all domains in both HIV+/- study participants. Based on the regression analyses, individuals with co-infection (MDR-TB/HIV+), as well as those who had longer duration of hospital stays experienced significantly lower cognitive performance in several domains. Poor cognitive performance was significantly related to older age and lower educational attainment. The presence of major depression or substance use disorders did not influence the significance of the findings. CONCLUSIONS: Adults with MDR-TB have significant neurocognitive impairment, especially if HIV positive. An integrated approach is necessary in the management of MDR-TB as cognitive health influences the ability to adhere to chronic treatment, clinical outcomes and functionality.
Authors: Andrew Tomita; Suvira Ramlall; Thirusha Naidu; Sbusisiwe Sandra Mthembu; Nesri Padayatchi; Jonathan K Burns Journal: J Nerv Ment Dis Date: 2019-04 Impact factor: 2.254
Authors: Norma Kabuba; J Anitha Menon; Donald R Franklin; Stian Lydersen; Robert K Heaton; Knut A Hestad Journal: Neuropsychology Date: 2018-03-05 Impact factor: 3.295
Authors: Christina M Marra; Yu Zhao; David B Clifford; Scott Letendre; Scott Evans; Katherine Henry; Ronald J Ellis; Benigno Rodriguez; Robert W Coombs; Giovanni Schifitto; Justin C McArthur; Kevin Robertson Journal: AIDS Date: 2009-07-17 Impact factor: 4.177
Authors: Robert K Heaton; Donald R Franklin; Reena Deutsch; Scott Letendre; Ronald J Ellis; Kaitlin Casaletto; Maria J Marquine; Steven P Woods; Florin Vaida; J Hampton Atkinson; Thomas D Marcotte; J Allen McCutchan; Ann C Collier; Christina M Marra; David B Clifford; Benjamin B Gelman; Ned Sacktor; Susan Morgello; David M Simpson; Ian Abramson; Anthony C Gamst; Christine Fennema-Notestine; David M Smith; Igor Grant Journal: Clin Infect Dis Date: 2014-10-31 Impact factor: 20.999
Authors: Monica M Diaz; Marcela Gil Zacarías; Patricia Sotolongo; María F Sanes; Donald J Franklin; María J Marquine; Mariana Cherner; Cesar Cárcamo; Ronald J Ellis; Serggio Lanata; Patricia J García Journal: Front Neurol Date: 2021-06-17 Impact factor: 4.086